Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
Abstract
Vaccine mediated immune mediated thrombocytopenia (ITP) is exceedingly rare. We present a case of a young female who developed severe refractory ITP with multiple bleeding sites post second dose of COVID-19 vaccination. She was treated with a combination of romiplostim and mycophenolate mofetil that resulted in rapid platelet count recovery.
Document Type
Article
Publication Date
11-6-2021
Digital Object Identifier (DOI)
https://doi.org/10.1002/ccr3.5035
Repository Citation
Nutalapati, Snigdha; Gupta, Garima; and Hildebrandt, Gerhard C., "Rapid Response to Mycophenolate Mofetil in Combination with Romiplostim in a Case of Severe Refractory Immune Thrombocytopenia Post COVID-19 Vaccination" (2021). Internal Medicine Faculty Publications. 267.
https://uknowledge.uky.edu/internalmedicine_facpub/267
Notes/Citation Information
Published in Clinical Case Reports, v. 9, issue 11, e05035.
© 2021 The Authors
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.